Items tagged with Treatment

Technical brief: Access to TB testing and treatments: GeneXpert and delamanid (post with simple image)

Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.

Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research (post with simple image)

A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.

Call to Action: Shorter and more effective treatment for all people suffering from drug-resistant TB (post with simple image)

Sign up for a Call to Action for accelerating the implementation of shorter and more effective treatment for all people with drug-resistant TB.

Survey: Provider attitudes to, and interest in, long-acting formulations of TB treatment (post with simple image)

Healthcare providers and policymakers in LMICs are invited to take part in an online survey assessing their perspectives on long-acting TB preventive treatment.

The rejection of the bedaquiline patent opposition in Indonesia raises the risk of difficulty in accessing optimal TB therapy (post with simple image)

The patent opposition was submitted by the Indonesia AIDS Coalition and Indonesia for Global Justice in November 2022 and was rejected by a decision from the Judiciary Panel on 9 November 2023.

WHO Rapid Communication: TB preventive treatment (post with simple image)

The World Health Organization announces forthcoming updates on TB preventive treatment.

TAG's 2023 Pipeline Report: TB Treatment (post with simple image)

Treatment Action Group launches the 2023 Tuberculosis Treatment Pipeline Report.

Mid-campaign report highlights what’s needed to win better, shorter TB treatments for all by end of 2024 (post with simple image)

With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.

Urgent call for Europe to improve treatment access for TB (post with simple image)

Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe.

Shorter TB treatment regimen shown to be safe and effective in operational research led by WHO (post with simple image)

National TB programs in 13 countries worked with WHO/Europe from 2020 to 2023 to examine treatment outcomes for people on 9-month treatment regimens for MDR-TB.

Page 107 of 107 · Total posts: 0

←First 106 107